+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin use and the risk of esophageal cancer: a population-based case-control study



Statin use and the risk of esophageal cancer: a population-based case-control study



Expert Opinion on Drug Safety 12(3): 293-298



The aim of this study was to investigate whether the use of statins was associated with esophageal cancer risk. A population-based case-control study was conducted in Taiwan. Cases consisted of all patients who were aged 50 years and older and had a first-time diagnosis of esophageal cancer for the period between 2004 and 2010. The controls were matched to cases by age, sex and index date. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by using multiple logistic regression. A total of 197 esophageal cancer cases and 788 controls were examined. The unadjusted ORs for any statin prescription was 0.86 (95% CI = 0.56 - 1.34) and the adjusted OR was 0.96 (95% CI = 0.59 - 1.58). Compared with no use of statins, the adjusted ORs were 0.77 (95% CI = 0.39 - 1.55) for the group having been prescribed statins with cumulative defined daily dose (DDDs) below 115 and 1.16 (95% CI = 0.63 - 2.14) for the group with cumulative statin use of 115 DDDs or more. The present data do not provide evidence to support either beneficial or harmful associations between statin use and esophageal cancer risk.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911457

Download citation: RISBibTeXText

PMID: 23470154

DOI: 10.1517/14740338.2013.778241


Related references

Statin use and the risk of bladder cancer: a population-based case-control study. Expert Opinion on Drug Safety 11(5): 733-738, 2013

Statin use and the risk of pancreatic cancer: a population-based case-control study. Pancreas 40(5): 669-672, 2011

Statin use and the risk of kidney cancer: a population-based case-control study. Expert Opinion on Drug Safety 11(4): 543-549, 2012

Statin use and the risk of colorectal cancer: a population-based case-control study. World Journal of Gastroenterology 17(47): 5197-5202, 2012

Statin use and the risk of breast cancer: a population-based case-control study. Expert Opinion on Drug Safety 13(3): 287-293, 2014

Statin use and the risk of female lung cancer: a population-based case-control study. Lung Cancer 75(3): 275-279, 2012

Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010. Cancer Epidemiology 38(1): 42-47, 2014

Population-based case-control study on risk factors for esophageal cancer in five high-risk areas in China. Asian Pacific Journal of Cancer Prevention 11(6): 1631-1636, 2011

Mutagenic drinking water and risk of male esophageal cancer: a population-based case-control study. American Journal of Epidemiology 150(5): 443-452, 1999

Atorvastatin correlates with decreased risk of esophageal cancer: a population-based case-control study from Taiwan. Libyan Journal of Medicine 7, 2012

Dietary acrylamide intake and risk of esophageal cancer in a population-based case-control study in Sweden. International Journal of Cancer 128(3): 676-681, 2011

Does family history of cancer modify the effects of lifestyle risk factors on esophageal cancer? A population-based case-control study in China. International Journal of Cancer 128(9): 2147-2157, 2011

Population-based case-control family study on risk factors of esophageal cancer in high incidence area. Zhonghua Yu Fang Yi Xue Za Zhi 43(7): 597-600, 2010

Incidence and risk factors for esophageal cancer following achalasia treatment: national population-based case-control study. Diseases of the Esophagus 2019, 2019

Statin use and the risk of gallstone disease: a population-based case-control study. Expert Opinion on Drug Safety 11(3): 369-374, 2012